Supernus Pharmaceuticals | SUPN - Trade Creditors


Supernus Pharmaceuticals reported $10.17M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Abbott USD 4.68B 439M Mar/2026
ANI Pharmaceuticals USD 69.69M 7.11M Mar/2026
Aurora Cannabis CAD 9.31M 58.72M Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Canopy Growth CAD 34.82M 14.85M Mar/2026
Cara Therapeutics USD 3.22M 859K Dec/2025
Corcept Therapeutics USD 33.31M 7.14M Mar/2026
Eisai JPY 75.89B 9.6B Mar/2026
Eli Lilly USD 5.03B 350M Mar/2026
Novo Nordisk DKK 14.8B 4.96B Mar/2026
Pacira USD 14.01M 1.14M Mar/2026
Perrigo USD 434.8M 39.7M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
Supernus Pharmaceuticals USD 10.17M 97.63M Mar/2026
United Therapeutics USD 498.3M 491.2M Mar/2026
Xeris Pharmaceuticals USD 11.47M 8.39M Mar/2026